Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government

Initial supply of 18 million doses of A(H1N1) influenza vaccine

09-Sep-2009 - Brazil

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced it has signed an agreement with Butantan Institute for the production and supply of a vaccine against the novel A(H1N1) influenza virus for the Brazilian Government. This contract was announced during a state visit to Brazil by French President Nicolas Sarkozy.

The order from the Brazilian Ministry of Health provides for the initial supply of 18 million doses of the new A(H1N1) influenza virus vaccine: one million doses in final presentation and 17 million doses in bulk form. The agreement includes an option for an additional 15 million doses of A(H1N1) vaccine should the World Health Organization (WHO) request influenza manufacturers to switch production from the regular Southern Hemisphere Seasonal influenza vaccine to the Pandemic A(H1N1) vaccine.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances